These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10582823)

  • 21. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
    Hylek EM; Regan S; Go AS; Hughes RA; Singer DE; Skates SJ
    Ann Intern Med; 2001 Sep; 135(6):393-400. PubMed ID: 11560452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 24. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey of oral vitamin K use by anticoagulation clinics.
    Libby EN; Garcia DA
    Arch Intern Med; 2002 Sep; 162(16):1893-6. PubMed ID: 12196089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.
    Fetrow CW; Overlock T; Leff L
    J Clin Pharmacol; 1997 Aug; 37(8):751-7. PubMed ID: 9378848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding risks and response to therapy in patients with INR higher than 9.
    Pagano MB; Chandler WL
    Am J Clin Pathol; 2012 Oct; 138(4):546-50. PubMed ID: 23010709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vitamin K1: an option to reduce warfarin's activity.
    Harrell CC; Kline SS
    Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review.
    Wilson SE; Watson HG; Crowther MA
    CMAJ; 2004 Mar; 170(5):821-4. PubMed ID: 14993179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
    Zhang H; Li M; Ao XL; Dong YJ; Dong L
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.
    Baker P; Gleghorn A; Tripp T; Paddon K; Eagleton H; Keeling D
    Br J Haematol; 2006 May; 133(3):331-6. PubMed ID: 16643436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of various phytonadione (vitamin K1) administration routes in achieving warfarin reversal.
    Laible B
    S D Med; 2007 Apr; 60(4):158-9. PubMed ID: 17555152
    [No Abstract]   [Full Text] [Related]  

  • 37. Critical international normalized ratio results after hours: To call or not to call?
    Korn D; Sean McMurtry M; George-Phillips K; Bungard TJ
    Can Fam Physician; 2017 Mar; 63(3):e170-e176. PubMed ID: 28292814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
    Shetty HG; Backhouse G; Bentley DP; Routledge PA
    Thromb Haemost; 1992 Jan; 67(1):13-5. PubMed ID: 1615468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
    Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
    Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.